Syneos Health, Inc. (NASDAQ:SYNH) traded at $65 at last check on Friday, Nov 20, making an upward move of 4.22% on its previous day’s price.
Looking at the stock we see that its previous close was $62.37 and the beta (5Y monthly) reads 1.82 with the day’s price range being $61.59 – 65.13. The company has a 12-month trailing PE ratio of 35.71. In terms of its 52-week price range, SYNH has a high of $74.25 and a low of $30.02. The company’s stock has gained about 11.61% over that past 30 days.
Syneos has a market cap of $6.57 Billion and is expected to release its quarterly earnings report on Feb 18, 2021- Feb 22, 2021. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the SYNH stock to lose ahead of the earnings release. Estimates by analysts give the company expected earnings per share (EPS) of $1.11, with the EPS growth for the year raised at $3.4 for 2020 and $4.15 for next year. These figures represent 0.05% and at 0.22% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $1.14 Billion, with a low of $1.13 Billion and a high of $1.22 Billion. The median projection represents growth adding up to -5.8% compared to sales earnings for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecasts for 2020 are expected to hit $4.42 Billion, or -5.6% down from figures reported last year.
On the other hand, looking at the outlook for the SYNH stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of Hold. Long term indicators on average place the stock in the category of 100% Buy.
Let’s briefly compare Syneos (SYNH) stock to its peers. We find that today’s price change of +4.22% and +25.75% over the past 12 months for SYNH betters that of Cerner Corp (CERN), which has seen its stock price rise 0.52% in the latest trading session and is +6.98% over the last one year. Another of its peers 10X Genomics Inc (TXG) has climbed 1.42% today, and is +126.05% up over the past year, while Invitae Corp (NVTA) is also up 4.22% yet its price remains in the green at 25.75% over the same period. Cerner has a P/E ratio of 28.65 compared to Syneos 35.71 and 10X’s 0. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at -0.68% and -0.75%, respectively, in early deals.
Coming back to Syneos Health, Inc. (NASDAQ:SYNH), we note that the average 3-month trading volume was 743.77 Million, while that of the preceding 10-day period stands at 587.17 Million. Current shares outstanding are 104Million.
According to data from Thomson Reuters, insiders hold 0.22% of the company’s shares while institutions hold 103.47%. The data shows that short shares as of October 29, 2020, stood at 5.63 Million at a short ratio of 7.86. This represents a 5.42% Short interest in Shares outstanding on October 29, 2020. Shares short dropped in October from the previous month at 6.14 Million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock +9.29% up in year-to-date price movement.